Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor
quality of life for those undergoing treatment for cancer and those surviving cancer. Many …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major, dose-limiting side effect of
treatment with neurotoxic cancer treatments which can result in long-term impairment …

The increased survival of cancer patients has raised growing public health concern on
associated long-term consequences of antineoplastic treatment. Chemotherapy-induced …

Oxaliplatin (OXA) is a platinum compound primarily used in the treatment of gastrointestinal
cancer. OXA-induced peripheral neurotoxicity (OXAIPN) is the major non-hematological …

This chapter summarizes the current knowledge of predisposing factors of CIPN
development. These predisposing factors can be classified as intrinsic (ie, demographics …

Objective To assess the contribution of large and small nerve fiber alteration in
erythromelalgia (EM). Methods Thirty-three EM patients were included and underwent …

In this study, we predicted the core active compounds of Huangqi Guizhi Wuwu decoction in
treatment of oxaliplatin-induced peripheral neuropathy and the related potential mechanism …

Objective Oxaliplatin-induced peripheral neuropathy (OIPN) is an unwanted side effect of
oxaliplatin chemotherapy treatment. OIPN manifests in an acute phase that lasts a few days …

Background Clinical guidelines recommend altering chemotherapy treatment by decreasing,
delaying, or discontinuing dosing in patients who are experiencing chemotherapy-induced …

背景在结直肠癌辅助化疗方案中使用奥沙利铂已被证明能以增加毒副作用为代价提高总生存率.
奥沙利铂对老年患者的毒副作用发生率和严重程度可能更高, 而老年患者的获益可能更少 …